BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Ki Yong Choi Demands Release of Cryo-Cell International (CCEL)'s Financial Results for the Quarter Ended May 31, 2012 Prior to the Annual Meeting


7/9/2012 10:59:59 AM

SAN FRANCISCO, July 6, 2012 /PRNewswire/ -- Ki Yong Choi, who owns approximately 19.6% of the outstanding shares of Cryo-Cell International, Inc. (OTCBB: CCEL), today issued the following letter to stockholders of Cryo-Cell.

Dear Fellow Cryo-Cell Stockholder:

On July 5, 2012 Cryo-Cell International, Inc. issued a press release which included the following quote by Mr. George Gaines, chairman of the company's Compensation Committee, "David and Mark Portnoy know exactly what it takes to reverse the company's downward trend in revenue. Their plan is already showing positive results."

As the largest stockholder, I want to know what these "positive results" consist of. I believe that management should share the company's financial results for the quarter ended May 31, 2012 with the company's stockholders prior to the annual meeting; these results include, but are not limited to, revenues, cost of revenues, operating expenses with sales and marketing broken out, net income or net loss, cash and securities balance, and uses of cash. Stockholders should have this information in order to make an informed decision when voting and to determine for themselves whether the company is truly "showing positive results".

We thank you and look forward to your support.

Ki Yong Choi

Investor Contact:
Alliance Advisors LLC.
Call Toll Free: (877) 777-2338;
Banks and Brokers Call Collect: (973) 873-7700.

SOURCE Ki Yong Choi



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->